UBS Group (NYSE:UBS) Earnings Call Presentation

UBS's Position on Regulatory Proposals - UBS supports enhancing regulation post-Credit Suisse but opposes the proposed capital measures as disproportionate and not internationally aligned[10] - UBS supports most proposals if they are proportionate, targeted, and internationally aligned[13] - UBS strongly opposes extreme measures misaligned internationally that don't address lessons from the Credit Suisse crisis[14] Impact of Proposed Capital Measures - Proposed changes to the Capital Adequacy Ordinance (CAO) would eliminate approximately $11 billion in UBS Group AG CET1 capital, representing about 15% of the total[10] - The CAO proposals would understate UBS's CET1 ratio by approximately 2 percentage points[10] - The sum of proposed capital measures would result in the strictest regime among peers[15] - The proposed capital measures would make UBS a pronounced outlier and understate its stated CET1 ratio[17] Specific Concerns Regarding Capital Deductions - Full deduction of capitalized software lacks regulatory and economic justification[22] - CAO proposals would eliminate approximately $45 billion of CET1 capital related to capitalized software at the Group level[21] - Deduction of temporary difference Deferred Tax Assets (TD DTAs) would be misaligned with other major jurisdictions and would not reflect realizable asset value[28] - Prudent Valuation Adjustment (PVA)-related measures should not be based on business combination accounting[30]